Infectious Disease Alert – October 1, 2013
October 1, 2013
View Issues
-
Valganciclovir Improves Survival in Patients with Glioblastoma
Glioblastoma is one of the most aggressive solid tumors, with a median overall survival of 12 to 14 months and a two-year survival of 15% to 26%. -
More Direct-Acting Antiviralsfor Treatment of Hepatitis C
-
Naegleria fowleri Amoeba Rarely Acquired, Rarely Survived
In 2011, 2 men died of amebic meningoencephalitis in Louisiana. -
Infectious Disease Malpractice: The $1.2 Million Miscommunication
Infectious diseases account for a significant percentage of emergency department (ED) visits each year and are frequent sources of litigation. -
Mortality Decline With the Use of a Sepsis Treatment Bundle
This large, multicenter, quality improvement project showed a dramatic reduction in mortality among patients with severe sepsis or septic shock after implementation of a sepsis treatment bundle. -
Infectious Disease Alert: Updates by Carol A. Kemper
-
Clinical Briefs in Primary Care
Evidence-based updates in primary care medicine By Louis Kuritzky, MD Supplement to Clinical Cardiology Alert, Clinical Oncology Alert, Critical Care Alert, Hospital Medicine Alert, Infectious Disease Alert, Neurology Alert, OB/GYN Clinical Alert, Primary Care Reports. -
Pharmacology Watch: More Side Effects of Fluoroquinolones Coming to Light